Clinical Trials Browser

Phase 2 × Interventional × Lubricant Eye Drops × Clear all

NCT06365853 2025-12-18

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Phase 2 Recruiting

Ovarian Neoplasms

NCT04327999 2024-01-18

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Phase 2 Terminated

9 enrolled 6 charts

Thyroid Neoplasms